114 related articles for article (PubMed ID: 2922496)
1. The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
Jansen JB; de Jong AJ; Lamers CB
Regul Pept; 1989 Feb; 24(2):209-13. PubMed ID: 2922496
[TBL] [Abstract][Full Text] [Related]
2. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
Jansen JB; Jebbink MC; Douglas BR; Lamers CB
Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
Jebbink MC; Jansen JB; Masclee AA; Lamers CB
Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
Miyasaka K; Nakamura R; Funakoshi A; Kitani K
Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
Niederau C; Liddle RA; Williams JA; Grendell JH
Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
Sakatani N; Inui A; Baba S
Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
8. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
Vijayan E; McCann SM
Life Sci; 1987 Feb; 40(7):629-34. PubMed ID: 3807652
[TBL] [Abstract][Full Text] [Related]
9. The effects of the cholecystokinin antagonist, proglumide, on gonadotropin release in the rat.
Vijayan E; McCann SM
Brain Res Bull; 1986 Apr; 16(4):533-6. PubMed ID: 3087585
[TBL] [Abstract][Full Text] [Related]
10. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
13. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
14. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
Shillabeer G; Davison JS
Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
[TBL] [Abstract][Full Text] [Related]
15. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
Watkins LR; Kinscheck IB; Mayer DJ
Brain Res; 1985 Feb; 327(1-2):169-80. PubMed ID: 3838690
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
Kellstein DE; Mayer DJ
Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
[TBL] [Abstract][Full Text] [Related]
18. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
Katsuura G; Hsiao S; Itoh S
Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
[TBL] [Abstract][Full Text] [Related]
19. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
Takács T; Nagy I; Pap A; Varró V
Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
[TBL] [Abstract][Full Text] [Related]
20. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
Gabryelewicz A; Kulesza E; Konturek SJ
Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]